Xiong Man, Yang Lei, Liu Xinfang, Luo Sidong, Wang Yeyang
School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Orthopaedic Center, the Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, People's Republic of China.
Int J Nanomedicine. 2025 Jun 14;20:7515-7532. doi: 10.2147/IJN.S518283. eCollection 2025.
Despite the rapid development of small diameter vascular graft (SDVG), the ability of synthetic grafts to facilitate tissue remodeling and regeneration remains an important challenge within regenerative medicine.
Based on our previous research work, silk fibroin (SF)/fibrin vascular grafts were successfully fabricated using electrospinning technology, and it was demonstrated that the grafts had superior mechanical strength, good cytocompatibility and histocompatibility. This indicated that the vascular graft was an ideal SDVG. We developed SF/fibrin vascular grafts with circumferentially aligned nanofibers to explore some of its properties in vivo.
The graft exhibited randomly arranged microstructure, excellent mechanical properties and compliance properties. These vascular grafts were transplanted into the abdominal aorta of rats, maintaining normal blood flow, vascular patency, and functionality. The M2/M1 ratio value in SF/fibrin grafts increased over time after implantation. Whereas the expression level of inflammatory cytokines initially increased and then eventually reached the normal levels. Moreover, the circumferentially aligned vascular grafts could guide the regeneration of neoarteries, endothelialization formation, enhanced functionality, rapid cellular infiltration and improved extracellular matrix (ECM) deposition, as well as generated more microvessels and fewer calcification.
Our research focused on the long-term performance in vivo of SF/fibrin tubular grafts, which could become a new type of SDVG and help guide the development of next-generation vascular grafts.
尽管小口径血管移植物(SDVG)发展迅速,但合成移植物促进组织重塑和再生的能力仍是再生医学领域的一项重要挑战。
基于我们之前的研究工作,利用静电纺丝技术成功制备了丝素蛋白(SF)/纤维蛋白血管移植物,结果表明该移植物具有优异的机械强度、良好的细胞相容性和组织相容性。这表明该血管移植物是一种理想的小口径血管移植物。我们开发了具有周向排列纳米纤维的SF/纤维蛋白血管移植物,以探索其在体内的一些特性。
该移植物呈现出随机排列的微观结构、优异的机械性能和顺应性。这些血管移植物被移植到大鼠腹主动脉中,维持了正常的血流、血管通畅性和功能。植入后,SF/纤维蛋白移植物中的M2/M1比值随时间增加。而炎性细胞因子的表达水平最初升高,最终达到正常水平。此外,周向排列的血管移植物可引导新生动脉再生、内皮化形成、增强功能、快速细胞浸润和改善细胞外基质(ECM)沉积,以及生成更多微血管和更少钙化。
我们的研究聚焦于SF/纤维蛋白管状移植物在体内的长期性能,其可能成为一种新型的小口径血管移植物,并有助于指导下一代血管移植物的开发。